Journals / Turkish Journal of Pharmaceutical Sciences / 2021 / Cilt: 18 - Sayı: 3

Prophylaxis and Therapeutic Ability of Inactivated Dermatophytic Vaccine Against Dermatophytosis in the Rabbits as an Animal Model

Bir Hayvan Modeli Olarak Tavşanlarda Dermatofitoza Karşı İnaktive Dermatofitik Aşının Profilaksi ve Terapötik Yeteneği

Pages
86–90
Publication Date
2022-11-06
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

Conclusion: Inactivated vaccine gives animals durable protection and shortens the treatmenttime for infection with dermatophytosis.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Objectives: Dermatophytosis is a group of cutaneous diseases widely distributed in human and animals.
📊
Key Findings & Data:Results: The prepared vaccine showed prophylactic ability against infection with T. mentagrophytes for more than 6 months without requiringan adjuvant and also revealed at herapeutic ability in infected animals after a short time (16 days), compared with the control group.
💡
Conclusion & Impact:Conclusion: Inactivated vaccine gives animals durable protection and shortens the treatmenttime for infection with dermatophytosis.
🔬Design:Modeling & Simulation
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Abstract

Objectives: Dermatophytosis is a group of cutaneous diseases widely distributed in human and animals. It causes serious infection in some human cases and economic losses in farm animals. The primary aim of this study is to conduct an investigation of prophylaxis and a potential therapeutic vaccine against dermatophytosis. Materials and Methods: The rabbit was chosen as an animal model of dermatophytosis for a case control study conducted in two parts. Inactivated cells of Trichophyton mentagrophytes were prepared for use as a vaccine. The prophylaxis part included vaccination of rabbits with the prepared vaccine either alone or with Freund’s adjuvant, followed by infection with the same fungus. The second part included treatment of infected rabbits with an inactivated vaccine. Results: The prepared vaccine showed prophylactic ability against infection with T. mentagrophytes for more than 6 months without requiringan adjuvant and also revealed at herapeutic ability in infected animals after a short time (16 days), compared with the control group. Conclusion: Inactivated vaccine gives animals durable protection and shortens the treatmenttime for infection with dermatophytosis.

Özet

Amaç: Dermatofitoz, insan ve hayvanlarda yaygın olarak bulunan bir grup deri hastalığıdır. Bazı olgularda ciddi enfeksiyonlara ve çiftlik hayvanlarında ekonomik kayıplara neden olur. Bu çalışmanın temel amacı, profilaksi ve dermatofitoza karşı potansiyel bir terapötik aşı araştırması yapmaktır. Gereç ve Yöntemler: Tavşan, iki bölümden oluşan bir olgu kontrol çalışması için dermatofitozun hayvan modeli olarak seçilmiştir. Trichophyton mentagrophytes’in etkisizleştirilmiş hücreleri, aşı olarak kullanılmak üzere hazırlandı. Profilaksi kısmı, tavşanların hazırlanan aşı ile tek başına veya Freund adjuvanı ile aşılanmasını ve ardından aynı mantarla enfeksiyonu içermiştir. İkinci kısım, enfekte tavşanların etkisizleştirilmiş bir aşı ile tedavisini içeriyordu. Bulgular: Hazırlanan aşı, T. mentagrophytes ile enfeksiyona karşı 6 aydan fazla süreyle, bir adjuvana ihtiyaç duymadan profilaktik yetenek gösterdi ve ayrıca enfekte hayvanlarda, kontrol grubuna kıyasla kısa bir süre sonra (16 gün) terapötik yetenek gösterdi. Sonuç: İnaktive aşı, hayvanlara kalıcı koruma sağlar ve dermatofitoz ile enfeksiyon için tedavi süresini kısaltır.

🔖

Cite This Article

AL-JANABI, A. A. H. S., AL-KHIKANI, F. H. O. (2022). Prophylaxis and Therapeutic Ability of Inactivated Dermatophytic Vaccine Against Dermatophytosis in the Rabbits as an Animal Model. Turkish Journal of Pharmaceutical Sciences, Cilt: 18 - Sayı: 3, 86–90. https://ajindex.com/articles/654534

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (10)

  1. Deepe GS Jr. Prospects for the development of fungal vaccines. Clin Microbiol Rev. 1997;10:585-596.
  2. Yeo SF, Wong B. Current status of nonculture methods for diagnosis of invasive fungal infections. Clin Microbiol Rev. 2002;15:465-484. Spellberg B. Vaccine for invasive fungal infections. F1000 Med Rep. 2011;3:13. Portuondo DL, Ferreira LS, Urbaczek AC, Batista-Duharte A, Carlos IZ. Adjuvants and delivery systems for antifungal vaccines: current state and future developments. Med Mycol. 2015;53:69-89. Edwards JE. Fungal cell wall vaccines: an update. J Med Microbiol. 2012;61:895-903.
  3. Medici NP, Poeta MD. New insights on the development of fungal vaccines: from immunity to recent challenges. Mem Inst Oswaldo Cruz. 2015;110:966-973.
  4. Gudding R, Lund A. Immunoprophylaxis of bovine dermatophytosis. Can Vet J. 1995;36:302-306. Woodfolk JA. Allergy and dermatophytes. Clin Microbiol Rev. 2005;18:30- 43. Lillis JV, Dawson ES, Chang R, White CR Jr. Disseminated dermal Trichophyton rubrum infection-an expression of dermatophyte dimorphism. J Cutan Pathol. 2010;37:1168-1169.
  5. Warycha MA, Leger M, Tzu J, Kamino H, Stein J. Deep dermatophytosis caused by Trichophyton rubrum. Dermatol Online J. 2011;17:21. Kim S, Jo IH, Kang J, Joo SY, Choi J. Dermatophyte abscesses caused by Trichophyton rubrum in a patient without pre-existing superficial dermatophytosis: a case report. BMC Infect Dis. 2016;16:298. Mousa WS, Eman-Abdeen. Review: overview on bovine dermatophytosis. International J Veterinary Sciences and Animal Husbandry. 2018;3:16-19.
  6. Vermount SM, Brouta FD, Descamps FF, Losson BJ, Mignon BR. Evaluation of immunogenicity and protective efficacy of a Microsporum canis metalloprotease subunit vaccine in guinea pigs. FEMS Immun Med Microbiol. 2004;40:75-80.
  7. Cambier L, Băgut ET, Helinen MP, Tabart J, Antoine N, Mignon B. Assessment of immunogenicity and protective efficacy of Microsporum canis secreted components coupled to monophosphoryl lipid-A adjuvant in a vaccine study using guinea pigs. Vet Microbiol. 2015;175:304-311.
  8. Nedosekov V, Martynyuk O, Stetsiura L, Evaluation of manufacturing specification of antifungal vaccines. Eduk Tech Inform. 2016;7:158-162.
  9. Kurtdede A, Ural K, Gazyagci S, Cingi CÇ. Usage of inactivated Microsporum canis vaccine in cats naturally infected with M. canis. Mikol Lek. 2007;14:19-21.
  10. Westhoff DK, Kloes MC, Orveillon FX, Farnow D, Elbers K, Mueller RS. Treatment of feline dermatophytosis with an inactivated fungal vaccine. Open Mycol J. 2010;4:1